Brazil restructures healthcare products and suppliers inspectorate
This article was originally published in Clinica
Executive Summary
The licensing and regulation in Brazil of healthcare products, their manufacturers and suppliers, as well as any related product marketing activities, will now be overseen by four new business units within the country's regulatory agency Anvisa.